Meena Patel
37Patents
10h-index
69Co-inventors
78Inventor score
Filing activity: Dec 19, 1997 → Aug 9, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6232320A | Cell adhesion-inhibiting antiinflammatory compounds | Chemistry; Metallurgy | 133 | Expired |
| US6579882B2 | Cell adhesion-inhibiting antiinflammatory compounds | Chemistry; Metallurgy | 129 | Expired |
| US6307047A | Prostaglandin endoperoxide H synthase biosynthesis inhibitors | Chemistry; Metallurgy | 28 | Expired |
| US8859566B2 | Substituted fused pyrimidine compounds | Chemistry; Metallurgy | 25 | Active |
| US7528134B2 | Acetamides and benzamides that are useful in treating sexual dysfunction | Chemistry; Metallurgy | 20 | Expired |
| US6472416B1 | Sulfonylphenylpyrazole compounds useful as COX-2 inhibitors | Chemistry; Metallurgy | 18 | Expired |
| US7875640B2 | Compounds as cannabinoid receptor ligands | Emerging Cross-Sectional Technologies | 15 | Active |
| US7872033B2 | Compounds as cannabinoid receptor ligands | Emerging Cross-Sectional Technologies | 14 | Active |
| US7875639B2 | Compounds as cannabinoid receptor ligands and uses thereof | Chemistry; Metallurgy | 14 | Active |
| US8338467B2 | Compounds as cannabinoid receptor ligands | Human Necessities | 10 | Active |
| US8481574B2 | Compounds as cannabinoid receptor ligands | Chemistry; Metallurgy | 9 | Active |
| US8501794B2 | Compounds as cannabinoid receptor ligands | Emerging Cross-Sectional Technologies | 9 | Active |
| US8173687B2 | Compounds as cannabinoid receptor ligands | Chemistry; Metallurgy | 9 | Active |
| US8058293B2 | Compounds as cannabinoid receptor ligands | Human Necessities | 9 | Active |
| US6960589B2 | Benzimidazoles that are useful in treating sexual dysfunction | Chemistry; Metallurgy | 8 | Expired |
| US7022728B2 | Benzimidazoles that are useful in treating male sexual dysfunction | Human Necessities | 7 | Expired |
| US8895592B2 | Compounds as cannabinoid receptor ligands | Chemistry; Metallurgy | 2 | Active |
| US8252797B2 | Heterocyclic compounds as adenosine receptor antagonist | Chemistry; Metallurgy | 2 | Active |
| US7115591B2 | Prostaglandin endoperoxide H synthase biosynthesis inhibitors | Chemistry; Metallurgy | 2 | Expired |
| US8507493B2 | Amide and amidine derivatives and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US7001895B2 | Prostaglandin endoperoxide H synthase biosynthesis inhibitors | Chemistry; Metallurgy | 2 | Expired |
| US9284316B2 | Substituted fused pyrimidine compounds | Chemistry; Metallurgy | 1 | Active |
| US11407758B2 | Tricyclic compounds, compositions and medicinal applications thereof | Human Necessities | 1 | Active |
| US8940751B2 | Purine compounds as prodrugs of A2B adenosine receptor antagonists, their process and medicinal applications | Chemistry; Metallurgy | 1 | Active |
| US8846730B2 | Compounds as cannabinoid receptor ligands | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.